CLINICAL_TRIALS
trial_result
· 2016-10-18
Clinical Trial Update: Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE [Phase 4]
Summary
Phase 4 clinical trial update reporting results on icatibant for hereditary angioedema, focusing on efficacy, safety and tolerability.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Hereditary Angioedema | Phase 4 | Status: COMPLETED | Results posted: 2016-10-18